创伤诱导性低钙血症的代谢组学与蛋白质组学变化
本研究在一级创伤中心纳入36例创伤患者(低钙组14例,正常钙组22例),排除孤立性颅脑损伤和穿透伤,入室时采血并在输血后样本被排除,采用偏最小二乘判别分析比较两组代谢组和蛋白质组特征,并用多重回归校正损伤严重度和入室碱剩余。校正后分析显示两组具有 distinct 代谢组和蛋白质组特征,低钙患者存在线粒体功能障碍(三羧酸循环破坏、脂肪酸氧化异常)、炎症失调(损伤相关分子模式升高、内皮细胞活化)、凝血通路异常及蛋白水解失衡伴组织破坏增加。结论认为创伤诱导性低钙血症与早期代谢组和蛋白质组变化相关,可能反映低钙创伤患者的独特病理,为未来机制研究和干预路径识别铺路。
要点
- 低钙组(离子钙≤1.0 mmol/L)14例 vs 正常钙组(离子钙>1.0 mmol/L)22例,校正损伤严重度和入室碱剩余后代谢组和蛋白质组特征不同。
- 低钙患者存在线粒体功能障碍证据:三羧酸循环破坏和脂肪酸氧化异常。
- 低钙患者存在炎症失调:损伤相关分子模式升高和内皮细胞活化。
- 低钙患者存在凝血通路异常和蛋白水解失衡伴组织破坏增加。
- 上述关联独立于损伤严重度、失血性休克和输血,可能反映独特病理。
适用人群与场景
- 一级创伤中心收治的受伤患者,入室时采血,输血后样本被排除;主要分析排除孤立性颅脑损伤和穿透伤,共36例(低钙组14例,正常钙组22例)。
诊断标准与关键阈值
- 低钙血症定义:离子钙≤1.0 mmol/L;正常钙定义:离子钙>1.0 mmol/L。
研究设计与关键结果
- 研究类型:在 Level 1 创伤中心开展的观察性研究,入室时采血并排除输血后样本,采用多重回归校正损伤严重度和入室碱剩余,使用偏最小二乘判别分析进行代谢组和蛋白质组比较。
- 主要分析纳入36例创伤患者(低钙组14例,正常钙组22例),排除孤立性颅脑损伤和穿透伤。
- 校正后分析显示正常钙和低钙患者具有 distinct 代谢组和蛋白质组特征。
- 低钙患者存在线粒体功能障碍证据(三羧酸循环破坏、脂肪酸氧化异常)、炎症失调(损伤相关分子模式升高、内皮细胞活化)、凝血通路异常和蛋白水解失衡伴组织破坏增加。
证据类型、等级与局限
- 证据类型:观察性研究(血浆代谢组学和蛋白质组学分析),原文未报告证据等级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为创伤诱导性低钙血症独立于损伤严重度、失血性休克和输血,与早期代谢组和蛋白质组变化相关,可能反映低钙创伤患者的独特病理。
- 作者认为本研究为未来实验铺路,以研究机制、识别可干预通路并改进严重损伤患者低钙血症的管理。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background: Trauma-induced hypocalcemia is common and associated with adverse outcomes, but the mechanisms remain unclear. Thus, we aimed to characterize the metabolomic and proteomic differences between normocalcemic and hypocalcemic trauma patients to illuminate biochemical pathways that may underlie a distinct pathology linked with this clinical phenomenon. Methods: Plasma was obtained on arrival from injured patients at a Level 1 Trauma Center. Samples obtained after transfusion were excluded. Multiple regression was used to adjust the omics data for injury severity and arrival base excess before metabolome- and proteome-wide comparisons between normocalcemic (ionized Ca 2+ > 1.0 mmol/L) and hypocalcemic (ionized Ca 2+ ≤ 1.0 mmol/L) patients using partial least squares-discriminant analysis. OmicsNet and Gene Ontology were used for network and pathway analyses, respectively. Results: Excluding isolated traumatic brain injury and penetrating injury, the main analysis included 36 patients (n = 14 hypocalcemic, n = 22 normocalcemic). Adjusted analyses demonstrated distinct metabolomic and proteomic signatures for normocalcemic and hypocalcemic patients. Hypocalcemic patients had evidence of mitochondrial dysfunction (tricarboxylic acid cycle disruption, dysfunctional fatty acid oxidation), inflammatory dysregulation (elevated damage-associated molecular patterns, activated endothelial cells), aberrant coagulation pathways, and proteolytic imbalance with increased tissue destruction. Conclusions: Independent of injury severity, hemorrhagic shock, and transfusion, trauma-induced hypocalcemia is associated with early metabolomic and proteomic changes that may reflect unique pathology in hypocalcemic trauma patients. This study paves the way for future experiments to investigate mechanisms, identify intervenable pathways, and refine our management of hypocalcemia in severely injured patients.
参考来源
- Schaid TR, LaCroix I, Cohen MJ, et al. METABOLOMIC AND PROTEOMIC CHANGES IN TRAUMA-INDUCED HYPOCALCEMIA. Shock. 2023. PMID: 37695733. doi:10.1097/SHK.0000000000002220
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。